Word

PROFERO

Status

Dead

Status Code

606

Status Date

Monday, March 20, 2017

Serial Number

86689495

Mark Type

4000

Filing Date

Friday, July 10, 2015

Published for Opposition

Tuesday, June 21, 2016

Abandoned Date

Monday, March 20, 2017

Trademark Owner History

The Translational Genomics Research Institute - Owner At Publication

Classifications

1 Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for medical use

5 Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes

42 Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping; Gene screening; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes

44 Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions

Trademark Events

Mar 20, 2017

Abandonment Notice Mailed - No Use Statement Filed

Mar 20, 2017

Abandonment - No Use Statement Filed

Aug 16, 2016

Noa E-Mailed - Sou Required From Applicant

Jun 21, 2016

Official Gazette Publication Confirmation E-Mailed

Jun 21, 2016

Published For Opposition

Jun 1, 2016

Notification Of Notice Of Publication E-Mailed

May 16, 2016

Approved For Pub - Principal Register

May 16, 2016

Examiner's Amendment Entered

May 16, 2016

Notification Of Examiners Amendment E-Mailed

May 16, 2016

Examiners Amendment E-Mailed

May 16, 2016

Examiners Amendment -Written

May 12, 2016

Previous Allowance Count Withdrawn

Apr 26, 2016

Withdrawn From Pub - Og Review Query

Apr 8, 2016

Approved For Pub - Principal Register

Mar 30, 2016

Teas/Email Correspondence Entered

Mar 30, 2016

Correspondence Received In Law Office

Mar 30, 2016

Teas Response To Office Action Received

Oct 2, 2015

Notification Of Non-Final Action E-Mailed

Oct 2, 2015

Non-Final Action E-Mailed

Oct 2, 2015

Non-Final Action Written

Sep 24, 2015

Assigned To Examiner

Jul 15, 2015

New Application Office Supplied Data Entered In Tram

Jul 14, 2015

New Application Entered In Tram